ASCENDIA PHARMACEUTICAL SOLUTIONS
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97008685
- Registration number
- 7868322
- Mark type
- Stylized text
- Filed
- 02 Sept 2021
- Published for opposition
- 12 Jul 2022
- Registered
- 15 Jul 2025
- Attorney of record
- James Klobucar
Goods and services
- Class 042 — Scientific and technological services: research and development of pharmaceuticals designed via physical means to be released into the body over a period of time
Owner
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
- Ascendia Pharmaceuticals, Inc., North Brunswick, NJ, US
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Mar 2025 — USE AMENDMENT FILED
- 30 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2024 — SOU EXTENSION 4 GRANTED
- 14 Aug 2024 — SOU EXTENSION 4 FILED
- 14 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2024 — SOU EXTENSION 3 GRANTED
- 12 Feb 2024 — SOU EXTENSION 3 FILED